SCHEMBL8250376

SCHEMBL8250376

CC1C=C(C(=O)CBr)C=CC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.33
PTPN1 P18031 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8213643 0.79 CCR2 (0.34)
SCHEMBL7968627 0.79 CHRNB2 (0.31)
SCHEMBL15943103 0.77 OPRD1 (0.31)
SCHEMBL13149375 0.74 OPRD1 (0.30)
SCHEMBL12816825 0.74 SLC6A3 (0.33) PTPN1
SCHEMBL18697855 0.71
SCHEMBL14369479 0.71
SCHEMBL23470770 0.69
SCHEMBL975860 0.67 GSK3B (0.34) GSK3BPTPN1
SCHEMBL14047884 0.67 HRH3 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007022415-A2 SUBSTITUTED 2-AMINOTHIAZOLES FOR TREATING NEURODEGENERATIVE DISEASES PHARMACOPEIA, INC. (US) 2007-02-22 WO disclosed